Polymyalgia rheumatica (PMR) that is triggered by immune checkpoint therapy can be treated with lower doses of prednisolone – between 5 mg to 7.5 mg per day – than is currently recommended by guidelines to treat regular PMR, clinicians state. Writing in the Annals of the Rheumatic Diseases, the rheumatologists from the Netherlands say their ...
PMR triggered by immunotherapy may require lower doses of prednisolone
By Nicola Garrett
15 Sep 2020